Why choose Pvigi

PVigi's commitment to expertise, tailored solutions, efficiency, and a deep understanding of the regional pharmacovigilance landscape, making us a reliable choice for CROs and pharmaceutical companies seeking outsourcing services in Bulgaria, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, Slovakia Austria, Belgium, Cyprus, Greece, Denmark, Finland, France, Germany, Iceland, Italy, Liechtenstein, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland Albania, Bosnia and Herzegovina, Croatia, Macedonia, Montenegro, Slovenia, Serbia Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Mongolia, Russian Federation, Tajikistan, Turkmenistan, Ukraine, Uzbekistan Israel, Tunisia, Turkey, United Urab Emirates, Vietnama.

Expertise and Compliance

PVigi boasts a team of professionals well-versed in pharmacovigilance regulations and practices specific to the Turkish, Middle Eastern, and African regions. We prioritize compliance with local and international regulations, ensuring that our clients' pharmacovigilance activities meet stringent standards. Our expertise in navigating diverse regulatory landscapes minimizes risk and ensures the safety and efficacy of pharmaceutical products in these regions.

Tailored Solutions and Efficiency

We understand that every client has unique needs and challenges. At PVigi, we offer personalized pharmacovigilance solutions designed to specific requirements. Leveraging cutting-edge technology and streamlined processes, we prioritize efficiency in our operations. Our goal is to optimize workflows, enhance data accuracy, and promptly address safety concerns, allowing our clients to focus on their core business while ensuring robust pharmacovigilance activities.

Regional Focus and Network

Operating in Turkey, the Middle East, and Africa, PVigi brings a deep understanding of the local market dynamics, cultures, and languages. Our regional focus allows us to provide tailored strategies that resonate with the diverse populations and regulatory nuances in these areas. Furthermore, our extensive network and established relationships within the healthcare ecosystem enable us to efficiently collaborate with local authorities, healthcare professionals, and stakeholders, fostering trust and facilitating seamless pharmacovigilance operations.

Our Service

We offer high quality and cost effective solutions with our expert team
Full Pharmacovigilance

Full Pharmacovigilance

We offer full pharmacovigilance operation including QPPV, LQPPV, LCPPV etc in many areas.

Clinical Research & Trial

Clinical Research & Trial

PVigi performs market access operations & Regulatory approval of the product. PVigi also handles safety submissions (SUSARs, DSURs, SUSAR-LLs) to applicable Regulatory Authorities, Central Ethic Committees / Central Institutional Review Boards and to investigators. Other safety submissions may also be performed when required by the sponsor or by NCAs or CECs/CIRBs or by investigators in specific countries.

Consultancy

Consultancy

Regulatory and approval, Pricing, Market Access in Turkey and MENA Region. Any information about market and local regulation will be shared with experienced team

 Literature Screening

Literature Screening

At Pvigi we offer global or local literature monitoring services which support signal management and inform the benefit-risk profile of drug safety process.

Regulatory Intelligence

Regulatory Intelligence

We gather and analyse of information on regulatory processes, requirements, and policies. It helps companies to understand the changing landscape of regulations and make informed decisions about their products.

Medical Information

Medical Information

We offer a spectrum of Medical Information Services delivered on a 24/7 basis by our bilingual native-speaking professionals.

Latest Updates

REGULATION ON THE SAFETY OF MEDICINAL PRODUCTS

Published Date: April 15, 2014 CHAPTER ONEPurpose, Scope, Basis and DefinitionsARTICLE 1 – (Amended:OG-21/7/2022-31899)(1) The purpose of this Regulation is to determine the procedures and principles regarding thesystematic monitoring of adverse reactions and benefit/risk balances, Read more…

Guideline on Good Pharmacovigilance Practices

APPENDIX I – Definitions Published Date: 12.06.2014Table of Contents EU Reference date, Union reference date. 3 Adverse event (AE), Adverse experience. 3 Adverse reaction, Adverse drug reaction (ADR), Suspected adverse (drug) reaction, Adverse effect, Undesirable Read more…

Get in Touch

Headquarter: Buyukdere Cd. Levent 199 Buildings 34330 Istanbul/Turkey

Office: 22nd Floor, Varsal Business Centre LLC, Baniyas Road, UAE Dubai

 

Contact Us